France· FR:64645960
FLECAÏNE L.P. 100 mg, gélule à libération prolongée
A flecainide product containing acétate de flécaïnide, registered in France by VIATRIS MEDICAL, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Flecainide is registered in 18 of 19 countries.
Countries holding a registration under ATC C01BC04 (flecainide), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Flecainide · ATC C01BC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of flecainide costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.49 in France to $2.20 in Switzerland — a ×4.5 gap.
- France: $0.49 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Flecainide · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.20
- IT Italy$0.70
- ES Spain$0.61
- FR France$0.49
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACÉTATE DE FLÉCAÏNIDE
- Manufacturer
- VIATRIS MEDICAL
- Country
- France (FR)
- ATC code
- C01BC04
- ATC class
- Flecainide
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400935805645plaquette(s) PVC PVDC aluminium de 30 gélule(s)EUR 10.53
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
342 interactions on record for flecainide.
Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flecainide · interactions on record
342 records
- 42 severe
- 164 moderate
- 15 minor
- 75 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- EliglustatA16AX10severe
46 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Flecainide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumApocard Retard 100 mgViatris Healthcare
- NetherlandsFlecaïnideacetaat retard 100 mg Teva, capsules met gereguleerde afgifteTeva Nederland B.V.
- CzechiaAMARHYTONSwyssi AG, Frankfurt am Main
- FinlandFlecainide OrionOrion Corporation
- ItalyFLEIDERINABRUNO FARMACEUTICI S.P.A.
- SwedenTambocor Retard 100 mg Depotkapsel, hårdViatris AB
- United KingdomFlecainide 100mg tabletsMedihealth (Northern) Ltd
- United StatesFlecainide AcetateHikma Pharmaceuticals USA Inc.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Aristocor
- Belgium · Apocard Retard, Flecainide Retard Eg
- Bulgaria · Амаритон, Фелкарид
- Cyprus · Flecardia
- Czechia · Amarhyton, Amarhyton 100 Mg
- Germany · Flecadura, Flecainid
- Denmark · Flecainid Sandoz, Flecainid Stada
- Spain · Apocard, Flecainida Aurovitas
- Finland · Flecainide Orion, Tambocor
- United Kingdom (Northern Ireland) · Flecainide Acetate Accord-Uk, Flecainide Acetate Brown & Burk Uk
- Greece · Amarhyton, Flecainide/Flexmed
- Croatia · Felkarid
- Ireland · Flecainide Teva, Tambocor
- Iceland · Flecainid Stada, Tambocor
- Italy · Almarytm, Flecainide Aurobindo
- Luxembourg · Apocard Retard, Flecainide Retard Eg
- Malta · Flecainide Acetate Aurobindo Pharma (Malta), Tambocor
- Netherlands · Flecainide Acetate Aurobindo, Flecainide Acetate Ratiopharm
- Norway · Flecainid Sandoz, Tambocor
- Poland · Flecainide Acetate Holsten
- Portugal · Amarhyton, Apocard
- Romania · Amarhyton, Tambocor
- Sweden · Tambocor, Tambocor Retard
- Slovenia · Felkarid
- Slovakia · Amarhyton 100 Mg, Amarhyton 50 Mg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/516e48f5-2eba-4111-b3a8-4ac4639e7a66 GET /v1/drugs/516e48f5-2eba-4111-b3a8-4ac4639e7a66?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64645960",
"date_amm": "2001-12-18",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ACÉTATE DE FLÉCAÏNIDE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about flecainide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.